Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eight At One Stroke: Attention Gangliosidoses A Registry Study for Patients With Gangliosidoses

NCT04624789 is registered in ClinicalTrials.gov with SphinCS Lyso Gemeinnutzige UG (Haftungsbeschrankt) as lead sponsor.

NCT NCT04624789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04624789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eight At One Stroke: Attention Gangliosidoses A Registry Study for Patients With Gangliosidoses
Lead sponsor
SphinCS Lyso Gemeinnutzige UG (Haftungsbeschrankt)
Phase
Observational
Overall status
Unknown status
Start date
June 8, 2020
Completion date
June 7, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

galactosialidosis, gangliosidoses, gm1 gangliosidosis, gm2 activator deficiency, gm2-gangliosidosis, variant b1, morquio b disease, sandhoff disease, sialidosis, tay-sachs disease